Therapeutic options for metastatic breast cancer

Author： Morris Patrick G   McArthur Heather L   Hudis Clifford A  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.6, 2009-04, pp. : 967-981

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Therapeutic Options for Chemotherapy-Resistant Metastatic Breast Cancer: The Epothilones

By Pronzato Paolo  

Drugs, Vol. 68, Iss. 2, 2008-01 ,pp. : 139-146

Adis International

Access to resources Recommend Favorite

Recurrent and/or metastatic thyroid cancer: therapeutic options

By Thalassinos Nicolaos   Vlassopoulou Varvara   Tzanela Marinela   Karavitaki Niki   Tzavara Ioanna  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 939-947

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness and safety of eribulin mesylate: a new therapeutic option in the treatment of metastatic breast cancer

By O'Sullivan Coyne Geraldine   Walsh Janice   Kelly Catherine M  

Expert Opinion on Drug Safety, Vol. 11, Iss. 4, 2012-07 ,pp. : 643-650

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Targets for Metastatic Prostate Cancer

By  

Current Drug Targets, Vol. 4, Iss. 3, 2003-04 ,pp. : 251-261

Bentham Science Publishers

Access to resources Recommend Favorite

Vinorelbine + mitomycin for metastatic breast cancer

By  

Inpharma, Vol. 1, Iss. 1304, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite